AHA yesterday sent a letter to the Department of Justice’s Antitrust Division expressing its serious concern with the adequacy of any remedy to resolve the anticompetitive impact of UnitedHealth Group’s acquisition of Change Healthcare. UHG in January announced its intent to combine its Optum health services subsidiary with Change Healthcare, a health care technology firm, to provide software and data analytics, technology-enabled services and research, advisory and revenue cycle management services.

At the time, AHA argued that the deal would distort “decisions about patient care and claims processing and denials to the detriment of consumers and health care providers and further increase UHG’s already massive market power.” In the newest letter AHA reiterated that “it is highly unlikely that any remedy will preserve the substantial level of competition between the parties that will be lost if the transaction is completed.”

Related News Articles

Headline
The 2025 AHA Annual Membership Meeting began today with Joanne Conroy, M.D., president and CEO of Dartmouth Health and 2024 AHA board chair, discussing the…
Headline
Rep. Nathaniel Moran, R-Texas, and Rep. Brad Schneider, D-Ill., both members of the House Ways and Means Committee, spoke to the AHA Annual Membership Meeting…
Headline
Rep. Mariannette Miller-Meeks, R-Iowa, participated in a fireside chat during the afternoon plenary session today at the 2025 AHA Annual Membership meeting. As…
Headline
Stacey Hughes, AHA's executive vice president for government relations and public policy, discussed key issues being considered on Capitol Hill that would…
Headline
John Ashbrook, founding partner, Cavalry LLC, and co-host of the Ruthless Podcast, yesterday moderated a panel discussion between Leigh Ann Caldwell, chief…
Headline
President Trump today released his discretionary spending budget blueprint for fiscal year 2026. The “skinny budget” request, which includes top line…